home All News open_in_new Full Article
Ipsen announces issuance of €500 million inaugural Rated Public Bond
Ipsen issued a €500 million inaugural rated public bond with a 3.875% coupon, maturing in March 2032. The issuance is part of Ipsen’s refinancing plan, which included a €1.5 billion revolving credit facility renewal. The bond supports Ipsen's growth strategy. Ipsen is a global biopharmaceutical company focused on Oncology, Rare Disease, and Neuroscience. Contact information for investors and media is provided. Forward-looking statements are based on Ipsen's management strategy, views, and assumptions.
today 5 h. ago attach_file Economics
attach_file
Economics
attach_file
Politics
attach_file
Society
attach_file
Politics
attach_file
Other
attach_file
Politics
attach_file
Other
attach_file
Other
attach_file
Society
attach_file
Other
attach_file
Other
attach_file
Politics
attach_file
Other
attach_file
Other
attach_file
Economics
ID: 4065242618